Search Results
Apr 21, 2026, 10:10 ET THE SKIN OF COLOR SOCIETY (SOCS) SUCCESSFULLY PRESENTS LANDMARK SYMPOSIUM CHAMPIONING EVIDENCE-BASED DERMATOLOGY AND COLLABORATION
March 18, 2027, in San Francisco, California.About the Skin of Color Society (SOCS)The Skin of Color Society (SOCS) is the world's leading professional dermatologic organization dedicated to advancing the field of skin of color dermatology. Founded in 2004 by Dr. Susan C. Taylor,
More news about: Skin of Color Society
Apr 21, 2026, 10:00 ET Nexben Transforms Health Benefits Through New Leadership, Names Distinguished Healthcare Executive as CEO
strategic shift. Lauren Sweda, Nexben's new chief growth officer will play a pivotal role in unlocking new opportunities. "I'm here because Nexben has skin in the game. We don't just talk about our solutions; we're actively using them," said Sweda."All of our employees, myself included, rely on the
More news about: Nexben
Apr 21, 2026, 09:06 ET LANCÔME NAMES DEMI MOORE AS GLOBAL AMBASSADOR
beauty. More than ever before, the brand aims to offer every woman the possibility to blossom and embrace her beauty and femininity whatever her age or skin color. Lancôme is present in 135 countries, with about 20,000 beauty advisers in as many points of sale offering sophisticated services and iconic products
More news about: Lancôme
Apr 21, 2026, 09:00 ET AQUA Dermatology Announces Partnership with Steele Dermatology
largest and most comprehensive full-service skin care providers in the Southeast, offering medical, surgical and cosmetic dermatology. For more than 25 years, the company has treated patients of all ages suffering from skin diseases, acne, sun damage, skin cancer, vein health issues, as well as those
More news about: AQUA Dermatology
Apr 21, 2026, 09:00 ET Revlon Introduces Teyana Taylor as the Face of Super Lustrous™
Revlon is among the leading global beauty companies, with some of the world's most iconic and desired brands and product offerings in color cosmetics, skin care, hair color, hair care and fragrances under brands such as Revlon, Revlon Professional, Elizabeth Arden, Almay, Mitchum, American Crew, Creme of
More news about: Revlon
Apr 21, 2026, 08:30 ET HKeybio Launches World's First NHP Hidradenitis Suppurativa Model with High Clinical Consistency to Tackle Global Drug R&D Bottleneck
Bridging the Gap: Why Rodent Models Fail in HS ResearchHidradenitis Suppurativa (HS) is a chronic, painful, and disfiguring inflammatory skin disease affecting approximately 1-4% of the global population, with over 50 million patients worldwide characterized by recurrent abscesses,
More news about: HKeyBio
Apr 21, 2026, 08:30 ET Lasix® ONYU Now Available from Walmart Specialty Pharmacy for Home Delivery
micropiston pump, fluid path, needle insertion and retraction mechanism, and a 29-gauge needle. After placement on the abdomen, the needle penetrates the skin when the device is activated. The Lasix ONYU Infusor slowly administers 80 mg furosemide over a period of five hours. This method results in significant
More news about: SQ Innovation
Apr 21, 2026, 08:15 ET Dr. Sam Rizk to Perform Live Surgery at Deep Plane Brazil 2026
for our patients."Dr. Rizk's work emphasizes restoring facial structure by repositioning deeper support layers rather than tightening surface skin alone. This structural approach allows surgeons to restore contour and balance at the anatomical level, producing refined and durable outcomes that
More news about: Sam Rizk, MD, FACS
Apr 21, 2026, 08:01 ET Seed Health and The Two Frontiers Project Launch Initiative to Explore Microbial Solutions to "Forever Chemicals"
is a pre- and probiotic studied in multiple human clinical trials and trusted by over two million people for its systemic benefits, including gut, skin, immune, and heart health. Seed's pipeline of gut-directed innovations, developed in collaboration with world-renowned researchers and clinicians, harnesses
More news about: Seed Health
Apr 21, 2026, 08:00 ET Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)
have been reported in patients treated with TNF blocker therapy, including infliximab products. Periodic skin examination is recommended for all patients, particularly those with risk factors for skin cancer.CONTRAINDICATIONSZYMFENTRA is contraindicated in patients with a previous severe
More news about: Celltrion
Apr 21, 2026, 07:00 ET DolCas Biotech: Beauty-From-Within Collagen Tripeptide Gets New Delivery Format
to stimulating collagen biosynthesis, emerging research suggests that GPH helps support skin hydration, and elasticity, softening the skin's roughness, deeper layers and reducing wrinkles.Demonstrated Skin BenefitsMorikol®, at a 1 g -daily recommended dose, is a potential game-changer
More news about: DolCas Biotech
Apr 21, 2026, 07:00 ET INVERA MEDICAL REPORTS 12-MONTH RESULTS FROM PILOT TRIAL OF INVERA INFUSION DEVICE SHOWING VEIN CLOSURE IN 90% OF PATIENTS, STATISTICALLY SIGNIFICANT QUALITY OF LIFE IMPROVEMENTS, AND EXCELLENT SAFETY
procedures. As the InVera device is non-thermal, there were no instances of complications associated with thermal ablation procedures, such as skin burns, nerve damage, or other thermal-related injuries.Technical procedural success, involving preparation of
More news about: InVera Medical
Apr 21, 2026, 02:35 ET Implantica announces landmark RefluxStop® study of 602 patients across 22 European centers, with up to 6.75-year follow-up, published in Nature's Scientific Reports
communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth (ticker: IMP A SDB). Visit
More news about: Implantica
Apr 20, 2026, 12:00 ET Preventative Beauty Trends Gain Momentum as Gen Z Begins Aesthetic Treatments Earlier
clients include education on skin cycles, hair growth patterns, and realistic expectations.Treatment plans are designed to be gradual and adaptable, ensuring that early intervention supports skin health without over-treatment.Balancing Technology and Skin IntegrityLaser by
More news about: Laser by Aleya
Apr 20, 2026, 10:40 ET A Moment of Xen Rapidly Scales Nationwide, Expanding Across Radio, Streaming, OTT and Live Experiences with Bosque Ranch
partnership with A MoMent of Xen reflects a shared vision of skin confidence that is both science-led and rooted in real impact on how people feel in their own skin. Together, we aim to empower individuals to feel comfortable and confident in their own skin, while raising awareness of the realities of pigmentation.
More news about: A Moment of Xen Show
Apr 20, 2026, 09:56 ET SKINCEUTICALS INTRODUCES FUTURE MINERAL UV DEFENSE SPF 50, A BREAKTHROUGH MINERAL SUNSCREEN WITH CLINICALLY PROVEN ANTI-AGING RESULTS
blendable protection across all skin tones in a lightweight, elegant texture, while helping defend against visible aging and support skin barrier recovery."Future Mineral UV Defense SPF 50 Clinically Proven Results:In a 12-week clinical study across all skin tones, Future Mineral UV Defense
More news about: SkinCeuticals
Apr 20, 2026, 09:06 ET LANCÔME WELCOMES ZOE SALDAÑA AS GLOBAL AMBASSADOR
beauty. More than ever before, the brand aims to offer every woman the possibility to blossom and embrace her beauty and femininity whatever her age or skin color. Lancôme is present in 135 countries, with about 20,000 beauty advisers in as many points of sale offering sophisticated services and iconic products
More news about: Lancôme
Apr 20, 2026, 08:30 ET LensDirect.com Launches Lolos Children's Eyewear with New OopsTech Innovation for Breakproof Durability
customized, comfortable fitActiveGrip - silicone nose pads and temple tips to prevent slippingHypoallergenic materials for sensitive skinEach pair is built to withstand the demands of daily use, from classrooms to playgrounds, with frames designed to bend, bounce back, and
More news about: LensDirect.com
Apr 20, 2026, 08:05 ET Accord BioPharma's IMULDOSA® (ustekinumab-srlf) Now Preferred Under Cigna Healthcare Commercial Plans
in patients receiving ustekinumab products who had pre-existing risk factors for developing non-melanoma skin cancer. Monitor all patients receiving IMULDOSA for the appearance of non-melanoma skin cancer. Closely follow patients greater than 60 years of age, those with a medical history of prolonged
More news about: Accord BioPharma
Apr 20, 2026, 08:00 ET Ampersand Biomedicines Presents Preclinical Data on AMP-220, a Gut-Targeted IL-22 AND-Body™ Therapeutic, at AAI 2026
barrier function and promoting mucosal healing in IBD, but its clinical utility has been limited by adverse activity in non-target tissues such as the skin. By programming IL-22 activity specifically to the gut, AMP-220 is designed to unlock the therapeutic promise of this pathway with improved precision,
More news about: Ampersand Biomedicines
Apr 20, 2026, 08:00 ET Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
soon as possible. The Company's preclinical pipeline includes development of an oral product candidate for treatment of ABSSSI (Acute Bacterial Skin and Skin Structure Infections), upon which a development program for treatment of inhaled anthrax is being planned in parallel.To learn more about
More news about: Acurx Pharmaceuticals, Inc.
Apr 20, 2026, 08:00 ET Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates
facilitating a strong in vivo efficacy in a range of preclinical models and good tolerability in non-human primates, showing no evidence of ocular, skin and lung toxicity, peripheral nerve damage, or bleedings. These data further support the clinical development of ADCE-T02 as a novel TF-targeting ADC
More news about: Adcendo
Apr 20, 2026, 08:00 ET Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates
facilitating a strong in vivo efficacy in a range of preclinical models and good tolerability in non-human primates, showing no evidence of ocular, skin and lung toxicity, peripheral nerve damage, or bleedings. These data further support the clinical development of ADCE-T02 as a novel TF-targeting ADC
More news about: Adcendo
Apr 20, 2026, 07:45 ET Hamidi Brings Scented Storytelling to Paris Modest Fashion Week
notes of praline, sandalwood, and incense.Each fragrance felt like a layer of identity, subtle yet expressive, designed to stay close to the skin and memory.Beyond the runway,
More news about: HAMIDI
Apr 20, 2026, 07:34 ET Hamidi Brings Scented Storytelling to Paris Modest Fashion Week
notes of praline, sandalwood, and incense.Each fragrance felt like a layer of identity, subtle yet expressive, designed to stay close to the skin and memory.Beyond the runway,
More news about: HAMIDI